This inventor holds 1 USPTO granted patent. Top assignee: Glaukos Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Olav G Bergheim: Innovator in Glaucoma Treatment
Introduction
Olav G Bergheim is a notable inventor based in Laguna Hills, CA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has led to the development of a specialized device aimed at improving patient outcomes.
Latest Patents
Bergheim holds a patent for a glaucoma treatment device. This device is designed to direct the flow of aqueous humor while bypassing the trabecular meshwork. The invention comprises an inlet section, an outlet section, a middle section, and at least one lumen for transmitting aqueous humor within the device. The lumen extends through at least one of the sections, with the outlet section being substantially perpendicular to the middle section, fitting within a conduit of aqueous humor outflow in the eye. This innovative design aims to enhance the effectiveness of glaucoma treatments.
Career Highlights
Bergheim is associated with Glaukos Corporation, a company dedicated to advancing the treatment of glaucoma. His work at Glaukos has positioned him as a key player in the development of cutting-edge medical devices. His contributions have been instrumental in pushing the boundaries of glaucoma treatment.
Collaborations
Throughout his career, Bergheim has collaborated with esteemed colleagues such as Hosheng Tu and Morteza Gharib. These partnerships have fostered an environment of innovation and have led to advancements in the field of ophthalmology.
Conclusion
Olav G Bergheim's work in developing a glaucoma treatment device showcases his commitment to improving patient care. His innovative spirit and collaboration with other experts in the field continue to drive advancements in glaucoma treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
